RelayHealth collaborating with CDC to provide H1N1 information
ATLANTA RelayHealth, a provider of healthcare connectivity services, is helping healthcare providers cope with the recent outbreak of influenza A (H1N1), and aiding the Centers for Disease Control and Prevention with monitoring of influenza antiviral prescribing activity nationwide via an authorized prescription data feed, the company announced Monday.
“Our hope is that the H1N1 threat continues to moderate,” stated Jim Bodenbender, RelayHealth’s SVP and general manager. “But whatever the threat level, our secure online interactive tools are available to assist physicians enrolled on the RelayHealth network to keep their patients informed of the latest credible health information at any time.”
Already, physicians are using RelayHealth’s HIPAA-compliant interactive service to broadcast messages securely over the Internet to their patients about the symptoms of H1N1 influenza and what to do if those patients think they have the disease, RelayHealth reported. RelayHealth has also made available H1N1 flu educational content on its network, which doctors can transmit to their patients
And RelayHealth’s Pharmacy Solutions Group is contributing to the national effort to track and limit the spread of the H1N1 flu by providing the CDC with a HIPAA-compliant data feed of antiviral prescriptions filled by a cross-sectional sample from more than 35,000 major chains, regional chains and independent pharmacies throughout the U.S. that have allowed their information to be shared.
RelayHealth provides the CDC with this authorized data feed every four hours, the company stated. On average, RelayHealth sends 400,000 to 500,000 prescription records daily to the CDC.
According to RelayHealth, the agency uses this data to monitor influenza antiviral prescribing activity across the country and shares the data with the U.S. Department of Health and Human Services.
“Our ability to swiftly assemble the data on antiviral prescriptions for the CDC is playing a role in the nation’s emergency preparedness effort,” stated Jeff Felton, president of RelayHealth’s Pharmacy Solutions Group.
CRN adds seven new companies to its roster
WASHINGTON The Council for Responsible Nutrition on Friday announced the addition of the following seven members to its roster.
Kansas City, Mo.-based CardioTabs specializes in manufacturing supplements designed specifically for cardiovascular health. The company regularly modifies its product formulations in response to the most current research on supplements and health resulting in products that are safe and effective.
Martek Biosciences Corp. develops nutritional products that promote health and wellness through every stage of life. Martek, based in Columbia, Md., has become a leader in fermentation technology and is an innovator in the research and development of products derived from microalgae.
Istanbul, Turkey-based Eczacibasi Ilac Pazarlama is a pharmaceutical company in Turkey that has recently expanded to develop dietary supplements. Although the company has a contract manufacturing agreement with Nutritional Laboratories International, they are not currently selling any products in the United States.
Accelovance is a clinical services company with a proven approach to accelerating clinical development by delivering optimal results through greater control and productivity. The Rockville, Md.-based company tailors its offerings of full CRO services, wholly owned clinical sites, patient recruitment and a clinical call center for a customized clinical solution.
NutraGenetics is a science-based developer of nutritional supplements, functional foods and nutraceuticals. NutraGenetics, based in Redondo Beach, Calif., also provides business consulting services in the healthcare field relating to new product development, product distribution, logistics and supply chain solutions.
NutrIQ of Alexandria, Va. is a consulting firm that works with suppliers and manufacturers of dietary supplements, conventional foods, functional foods and other over-the-counter products. The company specializes in nutrition marketing, communications, scientific, technical and regulatory services.
New York-based Sawaya Segalas provides investment banking services to brand-based businesses in the consumer industry.
Atherotech to roll out new cholesterol test
ATLANTA Atherotech and specialty retailer Any Lab Test Now last week announced the roll out of Atherotech’s VAP Cholesterol Test direct to consumers.
“We are excited to bring the VAP Test directly to consumers at such an attractive price point because it empowers them to manage their own health, gain more insight in their cardiovascular health and provide their health care provider with more information to accurately treat and manage their health,” stated Joe Neely, CEO Any Lab Test Now.
The VAP Cholesterol Test is an expanded cholesterol profile that identifies people at risk and is the first cholesterol test to directly measure LDL.
“Any Lab Test Now is a good fit for the VAP Test as it allows a growing population more access at an affordable price,” added Atherotech president Michael Mullen. “Our test gives people an opportunity to mitigate their risks that might have otherwise gone undetected.”
As part of the partnership, Any Lab Test Now will offer the VAP test individually for $79 and also include it as part of two value panels — the Metabolic Syndrome Panel ($229) and the Heart Health Panel ($279).
Founded in 1992, Any Lab Test Now is a franchise lab testing facility that provides medical lab tests to consumers and employers in a retail setting.